Active Ingredient: MEROPENEM; VABORBACTAM
Proprietary Name: VABOMERE
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: 1GM/VIAL;1GM/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N209776
Product Number: 001
Approval Date: Aug 29, 2017
Applicant Holder Full Name: REMPEX PHARMACEUTICALS INC A WHOLLY OWNED SUB OF MELINTA THERAPEUTICS LLC
Marketing Status:
Prescription
Patent and Exclusivity Information
